[Pharmacologic inhibition of the hypothalamo-hypophyseal center by combined gestagen-estrogen-corticosteroids in treatment of advanced breast cancer].
D000368:Aged; D001859:Bone Neoplasms; D001943:Breast Neoplasms / Q000188:drug therapy*; D003907:Dexamethasone / Q000627:therapeutic use*; D004357:Drug Synergism; D004967:Estrogens; D005260:Female; D006801:Humans; D006908:Hydroxyprogesterones / Q000627:therapeutic use*; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects*; D008113:Liver Neoplasms; D008875:Middle Aged; D009362:Neoplasm Metastasis; D012878:Skin Neoplasms; D013997:Time Factors
D004967:Estrogens; D006908:Hydroxyprogesterones; D003907:Dexamethasone
L'inhibition pharmacologique du centre hypothalamo-hypophysaire par l'association gestagène-oestrogène-corticostéroides dans le traitement des cancers mammaires avancés.